Otros idiomas Dyne Therapeutics, Inc.

Acciones

DYN

US26818M1080

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
24,73 ^USD	+4,37 %		+3,65 %	+85,94 %

25/03	El presidente y consejero delegado de Dyne Therapeutics, Joshua Brumm, dimite y John Cox es nombrado sucesor; las acciones caen un 7% antes de la OPV	MT
25/03	Dyne Therapeutics, Inc. anuncia cambios en la dirección	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer	27/03
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium	27/03
Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell	25/03
Dyne Therapeutics Announces CEO Transition	25/03
Dyne Therapeutics, Inc. Announces Management Changes	25/03
Dyne Therapeutics, Inc. Announces Chief Executive Officer Changes	25/03
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days	13/03
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days	13/03
Dyne Therapeutics Insider Sold Shares Worth $1,398,347, According to a Recent SEC Filing	05/03
Dyne Therapeutics's Q4 Net Loss Widens; Shares Down Pre-Bell	05/03
Dyne Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	05/03
Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	05/03
Dyne Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
Dyne Therapeutics Insider Sold Shares Worth $2,895,519, According to a Recent SEC Filing	04/03
Dyne Therapeutics Insider Sold Shares Worth $811,865, According to a Recent SEC Filing	04/03
Dyne Therapeutics Insider Sold Shares Worth $357,296, According to a Recent SEC Filing	04/03
Dyne Therapeutics Insider Sold Shares Worth $19,626,903, According to a Recent SEC Filing	29/02
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference	14/02
Dyne Therapeutics to Present at February Investor Conferences	01/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Dyne Therapeutics, Inc.

Acciones

DYN

US26818M1080

Otros idiomas

Filtros